1. Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
- Author
-
Duneesha De Fonseka, David T. Arnold, Anna J. Morley, Mary Brett, Nidhi Bhatt, Anthony Edey, Richard Daly, Anna C. Bibby, and Nick A. Maskell
- Subjects
Neutrophils ,Lymphocytes ,NLR ,Pleural fluid ,Mesothelioma ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Background As promising novel treatments develop for malignant pleural mesothelioma (MPM), early prognostication has become increasingly important. Circulating and local inflammatory cells are known to play a significant role in other tumour types. We assessed the proportion of lymphocyte populations within blood, pleural fluid and tumour stroma to prognosticate patients with MPM at diagnosis. Methods Consecutive patients diagnosed with biopsy-proven MPM were prospectively recruited to an observational cohort study and followed up for a minimum of 7.5 years. Blood and pleural fluid results at presentation were extracted from the medical records. Biopsy specimens were independently reviewed by 2 pathologists who scored the degree of lymphocytic and neutrophilic infiltration. Results Baseline results were available for 184 patients. The predominant pleural fluid cell type was calculable for 84 patients and 118 patients had biopsy specimens available for review. A low blood neutrophil/lymphocyte ratio (NLR
- Published
- 2022
- Full Text
- View/download PDF